Skip to content

Observational Study to Collect Safety Data and PROMs on Primary THA

Observational Study to Collect Safety Data and Patient-reported Outcomes Measures (PROMs) on Retrospective Primary Total Hip Arthroplasty Surgeries With Trinity Cup and Meije Duo Cementless Hip Stem

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06518993
Enrollment
116
Registered
2024-07-25
Start date
2024-04-19
Completion date
2025-06-20
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coxitis, Femoral Head Necrosis, Femoral Neck Fractures, Hip Arthritis, Osteoarthritis, Hip

Keywords

total hip arthroplasty

Brief summary

This observational study is designed to collect safety data and PROMs on retrospective primary total hipa arthroplasty surgeries with Trinity cup and Meije Duo cementless hip system

Detailed description

The major goal of this study is to collect safety and patient-reported outcomes measures (PROMs) data on Trinity cup in combination with Meije Duo cementless hip stem when used in primary total hip arthroplasty (THA). Data collected from this study will be fed into the Post-Market Surveillance (PMS) and Clinical Evaluation processes of the devices under assessment annually and support presentations at orthopaedic congresses and/or peer-reviewed publication(s) on mid- and long-term safety and clinical performance.

Interventions

DEVICETotal hip arthroplasty with a Trinity cup and a Meije Duo cementless stem

Subjects clinically suitable for a primary THR surgery with Trinity cup and Meije Duo cementless femoral stem.

Sponsors

Corin
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Both genders. * Adult subjects. * Subjects who received a primary THR with Trinity cup and Meije Duo cementless femoral stem. * The subject is willing to comply with the required follow-up visits as per protocol. * The subject has signed a Patient Informed Consent Form (PICF), specific to this study, and approved by the local EC.

Exclusion criteria

* Subjects under guardianship. * Subjects in the opinion of the Investigator/ investigative team who will be unable to comply with study procedures (Examples: recent psychotic or mania disorders, alcohol, drug or substance abusers) and/or those unable for any medical or other reason to comply with study procedures/visits.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of hip functional performance2 yearsImprovement of Oxford Hip Score (OHS)

Secondary

MeasureTime frameDescription
Confirmation of safety of the study devices2 yearsNumber, severity and causal relationship procedure of implant-related adverse events
Evaluation of outcome after hip arthroplasty2 yearsNumber, severity and causal relationship procedure of implant-related adverse events
Evaluation of clinical outcomes2 yearsImprovement of Harris Hip Score (HHS)
Assessment of health-related quality of life2 yearsChange of EQ-5D-5L
Assessment of patient's satisfaction2 yearsImprovement of patient's satisfaction following surgery using Self-Administered Patient Satisfaction Scale

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026